BURKITT LYMPHOMA
Clinical trials for BURKITT LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new BURKITT LYMPHOMA trials appear
Sign up with your email to follow new studies for BURKITT LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Boosted stem cells aim to speed recovery in aggressive blood cancers
Disease control OngoingThis study is testing whether specially grown cord blood stem cells can help patients with high-risk blood cancers recover their immune systems faster after a transplant. Participants receive a transplant using these expanded stem cells after strong chemotherapy. Researchers are …
Matched conditions: BURKITT LYMPHOMA
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
First-in-Human trial seeks safe dose for powerful new lymphoma combo
Disease control OngoingThis early-stage trial aims to find a safe and tolerable dose of a new drug, loncastuximab tesirine, when combined with a standard chemotherapy regimen (DA-EPOCH-R). It is for adults with aggressive types of B-cell lymphoma, including Burkitt lymphoma, who have not yet received m…
Matched conditions: BURKITT LYMPHOMA
Phase: PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New weapon against cancer enters human testing
Disease control OngoingThis is an early-stage study testing a new antibody drug called IMT-009 in people with advanced solid tumors or lymphomas that have stopped responding to standard treatments. The main goals are to find a safe dose, understand the side effects, and see if the drug helps shrink tum…
Matched conditions: BURKITT LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Immunitas Therapeutics • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC